Drug intelligence / Profile preview

C-Vitum

Development stage
Unknown
Lead developer
OLEOFARM
Modality
Small Molecules
Administration
Oral
01

Overview

C-Vitum is a dietary supplement brand developed by the Polish company Oleofarm, featuring L-ascorbic acid (vitamin C) as its active ingredient. It is primarily indicated for the treatment and prevention of vitamin C deficiency and for general nutritional supplementation. Vitamin C serves as a critical antioxidant, protecting cellular components from oxidative damage, and acts as a necessary cofactor for enzymes such as prolyl and lysyl hydroxylases, which are essential for the biosynthesis of collagen. This support for collagen production is vital for the structural integrity of skin, blood vessels, bones, and cartilage. C-Vitum is available in several oral delivery formats, including high-potency capsules, effervescent tablets, and prolonged-release formulations, to support immune health, nervous system function, and energy metabolism.

Brand names
C-Vitum
Other names
ascorbic acidvitamin CL-ascorbic acid
02

Targets

LH (Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1)

Beyond the preview

Go deeper on C-Vitum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C-Vitum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call